Back to results

Chief Development Officer

  • Montreal, QC, Canada

Full-time

Apply on LinkedIn About employer

Applications open in a new tab.

Job details

Job type
Full-time
Apply by
Posting language
English
Posted

Original job description

Chief Development Officer (CDO)

Galyx Therapeutics Inc.

Location: Montréal, Québec (residence in Montréal is required)

Annual base salary: CAD $100,000–$120,000

Performance bonus: Up to 15% of annual base salary

Stock options: Eligible to participate in the employee stock option pool, subject to plan terms and applicable approvals

About Galyx Therapeutics

Galyx Therapeutics is an early-stage immuno-oncology company working to translate innovative science into new treatment options for patients with cancer. Based in Montréal, we are advancing a first-in-class development program toward first-in-human clinical evaluation.

Galyx has secured Seed financing from CTI Life Sciences Fund, a leading Canadian biotechnology venture capital firm. With this backing, we are focused on executing a disciplined development strategy, generating decision-enabling data, and building the foundation for clinical development.

Joining Galyx means helping shape a company at a formative stage. You will have the opportunity to work closely with scientific founders, external experts, and investors. You will directly influence how promising research advances toward the clinic.

The Opportunity

We are seeking a hands-on Chief Development Officer to lead the execution of Galyx’s development plan.

This role combines scientific leadership with practical program management. You will translate the company’s strategy into an integrated development roadmap, coordinate external partners, manage budgets and timelines, and ensure that studies generate the evidence needed for clear development decisions.

Working closely with company leadership and specialists in biology, manufacturing, regulatory affairs, and clinical development, you will help advance the program through preclinical and translational milestones toward regulatory submissions and first-in-human studies.

This is a builder’s role: an opportunity for a scientifically rigorous, resourceful leader who enjoys taking ownership, solving problems, and delivering results in an entrepreneurial environment.

Key Responsibilities:

Execute the development plan

  • Own and maintain the integrated development plan, including milestones, budgets, timelines, dependencies, and decision criteria.
  • Coordinate preclinical, translational, manufacturing, regulatory, and early clinical-readiness activities.
  • Identify development risks early, recommend mitigation strategies, and adapt plans as new data emerge.
  • Provide clear progress updates and recommendations to company leadership and investors.

Lead preclinical and translational development

  • Oversee studies addressing efficacy, pharmacokinetics/pharmacodynamics, biodistribution, immunogenicity, safety pharmacology, and toxicology, as appropriate to the program.
  • Ensure studies are designed to answer critical development questions and meet applicable quality and regulatory expectations, including GLP requirements where appropriate.
  • Lead data review and interpretation, connecting experimental results to development decisions.
  • Develop biomarker and translational strategies that support the transition from preclinical research to clinical evaluation.

Coordinate manufacturing and regulatory readiness

  • Work with external CMC partners on process development, analytical methods, characterization, stability, and clinical-supply planning.
  • Coordinate with regulatory experts to prepare for CTA/IND submissions and regulatory interactions.
  • Support the preparation of development reports, Investigator’s Brochure content, and early clinical protocols.
  • Ensure scientific, manufacturing, and regulatory workstreams remain aligned.

Manage external partners and resources

  • Select and manage CROs, CDMOs, specialized laboratories, and consultants.
  • Define scopes of work, negotiate deliverables and budgets, and monitor performance.
  • Maintain high standards for data quality, documentation, and accountability.
  • Support grant applications, research collaborations, investor diligence, and relationships within the Montréal and Québec biotechnology ecosystem.

What You Bring

  • A PhD in immunology, oncology, pharmacology, or a related discipline, or an equivalent combination of advanced training and relevant experience.
  • Demonstrated industry experience in preclinical or translational drug development, ideally in oncology, immuno-oncology, or biologics.
  • Experience advancing programs toward regulatory submissions or first-in-human readiness.
  • Strong understanding of study design, PK/PD, biomarkers, safety assessment, and the relationship between preclinical evidence and clinical development.
  • Working knowledge of CMC development and the ability to coordinate effectively with manufacturing and analytical specialists.
  • Experience managing external service providers, development budgets, and project timelines.
  • The ability to communicate complex scientific information clearly and make practical, evidence-based recommendations.
  • An entrepreneurial mindset, strong judgment, and a willingness to contribute directly, not only oversee.
  • Ability to work effectively in French and English.
  • Eligibility to work in Québec and residence in Montréal.

Why Join Galyx?

  • Shape the program: Influence development strategy and execution at a pivotal stage.
  • Turn science into progress: Help move an innovative immuno-oncology program toward clinical evaluation.
  • Take meaningful ownership: Lead an integrated development effort with visibility across the company.
  • Build with venture backing: Join a Seed-financed company supported by CTI Life Sciences Fund.
  • Participate in long-term value creation: Become eligible to participate in the employee stock option pool.

Compensation

  • Annual base salary of CAD $100,000–$120,000, depending on experience and qualifications.
  • Performance-based bonus of up to 15% of annual base salary.
  • Eligibility to participate in the employee stock option pool, subject to plan terms and applicable approvals.

How to Apply

Send your CV or LinkedIn profile and a brief introduction describing your relevant drug-development experience to: yves.st-pierre@galyxtx.com

Please use “Chief Development Officer - Application” in the subject line.

More about this job

Responsibilities

Lead and maintain the integrated development plan, coordinating preclinical, translational, manufacturing, regulatory, and clinical-readiness activities while managing milestones, budgets, timelines, and risks. Oversee study design and data interpretation, manage external partners, and guide the program toward regulatory submissions and first-in-human studies.

Requirements

Requires a PhD in immunology, oncology, pharmacology, or a related discipline, or equivalent advanced training and relevant experience, along with industry experience in preclinical or translational drug development. Candidates should bring expertise in study design, PK/PD, biomarkers, safety assessment, CMC coordination, external-provider and budget management, and effective communication in French and English; eligibility to work in Québec and residence in Montréal are required.

Skills

  • Drug Development
  • Preclinical Development
  • Translational Development
  • Immuno-Oncology
  • Program Management
  • Study Design
  • Pharmacokinetics/Pharmacodynamics
  • Biomarker Strategy
  • Safety Assessment
  • CMC Development
  • Regulatory Readiness
  • CRO and CDMO Management
  • Budget Management
  • Risk Mitigation
  • Scientific Communication
  • French and English Communication

Benefits

  • Performance Bonus
  • Stock Options

Visa sponsorship

Not detected in the job text

Hiring contact email

yves.st-pierre@galyxtx.com

Categories

  • Science & Research
  • Healthcare
  • Management & Leadership

Keywords

  • Immuno-Oncology
  • Preclinical Drug Development
  • Translational Development
  • First-in-Human Studies
  • Integrated Development Plan
  • Efficacy Studies
  • Pharmacokinetics
  • Pharmacodynamics
  • Biodistribution
  • Immunogenicity
  • Safety Pharmacology
  • Toxicology
  • GLP
  • Biomarkers
  • CMC
  • Process Development
  • Analytical Methods
  • Stability
  • Clinical Supply Planning
  • CTA/IND Submissions
  • Investigator’s Brochure
  • Clinical Protocols
  • CROs
  • CDMOs
  • Budget Management
  • Risk Mitigation
  • Regulatory Affairs
  • Oncology
  • Biologics
  • Investor Diligence

Report this job

Get in touch
MovoJobs

How can we help?